Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 1, 2025
Quality assessment of cholic acid as an active pharmaceutical ingredient: Analytical method and resultsY Polak, C E M Hollak, E L Swart, et al.Critical Care Medicine|September 2, 1999
Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effectiveE L Swart, R J van Schijndel, A C van Loenen, et al.Therapeutic Drug Monitoring|August 12, 1999
Reversed-phase ion-pair HPLC method for the direct analysis of 1-OH midazolam glucuronide in human serumK M van Rij, D Compas, E L Swart, et al.Analytical and Bioanalytical Chemistry|August 18, 2012
Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometryJ C G den Burger, A J Wilhelm, A Chahbouni, et al.Heliyon|May 3, 2023
A validated HPLC-MS/MS method for simultaneously analyzing curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or fecesM A G M Kroon, H W M van Laarhoven, E L Swart, et al.Cancer Chemotherapy and Pharmacology|June 12, 2020
Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimizationR B Verheijen, E L Swart, J H Beijnen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Potential drug interactions in cancer therapy: a prevalence study using an advanced screening methodR W F van Leeuwen, E L Swart, E Boven, et al.Antimicrobial Agents and Chemotherapy|November 23, 2016
Pharmacokinetics of Anidulafungin in Critically Ill Intensive Care Unit Patients with Suspected or Proven Invasive Fungal InfectionsR J M Brüggemann, V Middel-Baars, D W de Lange, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 18, 2025
Exposure-response analysis of oral and intravenous imatinib in critically ill patients with COVID-19 acute respiratory distress syndromeM M Said, A M Braam, E Duijvelaar, et al.Cancer Chemotherapy and Pharmacology|April 11, 2020
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation studyL H Mammatas, A S Zandvliet, M Rovithi, et al.Pageof 2